Phosphodiesterase 3A (PDE3A) Deletion Suppresses Proliferation of Cultured Murine Vascular Smooth Muscle Cells (VSMCs) via Inhibition of Mitogen-activated Protein Kinase (MAPK) Signaling and Alterations in Critical Cell Cycle Regulatory Proteins
Open Access
- 1 July 2011
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 286 (29), 26238-26249
- https://doi.org/10.1074/jbc.m110.214155
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- PKA and Epac synergistically inhibit smooth muscle cell proliferationJournal of Molecular and Cellular Cardiology, 2010
- Controlling the Mdm2-Mdmx-p53 CircuitPharmaceuticals, 2010
- Role of Smooth Muscle Cells in the Initiation and Early Progression of AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Alterations in regulation of energy homeostasis in cyclic nucleotide phosphodiesterase 3B–null miceJCI Insight, 2006
- cAMP phosphodiesterase inhibitors potentiate effects of prostacyclin analogs in hypoxic pulmonary vascular remodelingAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2005
- Inflammation in atherosclerosisNature, 2002
- Immune Mechanisms in AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Suppression of arterial intimal hyperplasia by cilostamide, a cyclic nucleotide phosphodiesterase 3 inhibitor, in a rat balloon double‐injury modelBritish Journal of Pharmacology, 2000
- Molecular pathways of cyclic nucleotide-induced inhibition of arterial smooth muscle cell proliferationJournal of Cellular Physiology, 2000
- The Pathogenesis of Atherosclerosis — An UpdateNew England Journal of Medicine, 1986